位置:首页 > 蛋白库 > SYY_GEOSE
SYY_GEOSE
ID   SYY_GEOSE               Reviewed;         419 AA.
AC   P00952;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   03-AUG-2022, entry version 134.
DE   RecName: Full=Tyrosine--tRNA ligase;
DE            EC=6.1.1.1 {ECO:0000269|PubMed:1542120};
DE   AltName: Full=Tyrosyl-tRNA synthetase {ECO:0000303|PubMed:6315404};
DE            Short=TyrRS {ECO:0000303|PubMed:6315404};
DE            Short=TyrTS {ECO:0000303|PubMed:7120416};
GN   Name=tyrS;
OS   Geobacillus stearothermophilus (Bacillus stearothermophilus).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus.
OX   NCBI_TaxID=1422;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 2-124; 136-157
RP   AND 172-419.
RX   PubMed=6840095; DOI=10.1111/j.1432-1033.1983.tb07374.x;
RA   Winter G., Koch G.L.E., Hartley B.S., Barker D.G.;
RT   "The amino acid sequence of the tyrosyl-tRNA synthetase from Bacillus
RT   stearothermophilus.";
RL   Eur. J. Biochem. 132:383-387(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11.
RX   PubMed=3525162; DOI=10.1111/j.1432-1033.1986.tb09783.x;
RA   Waye M.M.Y., Winter G.;
RT   "A transcription terminator in the 5' non-coding region of the tyrosyl tRNA
RT   synthetase gene from Bacillus stearothermophilus.";
RL   Eur. J. Biochem. 158:505-510(1986).
RN   [3]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6315404; DOI=10.1002/j.1460-2075.1983.tb01665.x;
RA   Waye M.M.Y., Winter G., Wilkinson A.J., Fersht A.R.;
RT   "Deletion mutagenesis using an 'M13 splint': the N-terminal structural
RT   domain of tyrosyl-tRNA synthetase (B. stearothermophilus) catalyses the
RT   formation of tyrosyl adenylate.";
RL   EMBO J. 2:1827-1829(1983).
RN   [4]
RP   INTERACTION WITH TRNA(TYR), AND SUBUNIT.
RX   PubMed=3006039; DOI=10.1073/pnas.83.5.1189;
RA   Carter P., Bedouelle H., Winter G.;
RT   "Construction of heterodimer tyrosyl-tRNA synthetase shows tRNATyr
RT   interacts with both subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1189-1192(1986).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-45; GLU-152; THR-224;
RP   LYS-410 AND LYS-411.
RX   PubMed=1542120; DOI=10.1016/0022-2836(92)90991-r;
RA   Vidal-Cros A., Bedouelle H.;
RT   "Role of residue Glu152 in the discrimination between transfer RNAs by
RT   tyrosyl-tRNA synthetase from Bacillus stearothermophilus.";
RL   J. Mol. Biol. 223:801-810(1992).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, MOTIF, AND MUTAGENESIS OF LYS-230; PHE-231;
RP   GLY-232; LYS-233 AND THR-234.
RX   PubMed=10630994; DOI=10.1021/bi991675l;
RA   Xin Y., Li W., First E.A.;
RT   "The 'KMSKS' motif in tyrosyl-tRNA synthetase participates in the initial
RT   binding of tRNA(Tyr).";
RL   Biochemistry 39:340-347(2000).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF THR-40; HIS-45; HIS-48;
RP   LYS-82 AND ARG-86.
RX   PubMed=11023793; DOI=10.1006/jmbi.2000.4125;
RA   Xin Y., Li W., Dwyer D.S., First E.A.;
RT   "Correlating amino acid conservation with function in tyrosyl-tRNA
RT   synthetase.";
RL   J. Mol. Biol. 303:287-298(2000).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, MOTIF, AND MUTAGENESIS OF ASP-78; TYR-169;
RP   GLN-173; ASP-194 AND GLN-195.
RX   PubMed=11023794; DOI=10.1006/jmbi.2000.4126;
RA   Xin Y., Li W., First E.A.;
RT   "Stabilization of the transition state for the transfer of tyrosine to
RT   tRNA(Tyr) by tyrosyl-tRNA synthetase.";
RL   J. Mol. Biol. 303:299-310(2000).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LEU-322; PHE-323; SER-324;
RP   GLY-325 AND PHE-339.
RX   PubMed=11401566; DOI=10.1021/bi010208c;
RA   Gaillard C., Bedouelle H.;
RT   "An essential residue in the flexible peptide linking the two
RT   idiosynchratic domains of bacterial tyrosyl-tRNA synthetases.";
RL   Biochemistry 40:7192-7199(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=7120416; DOI=10.1016/0022-2836(82)90255-8;
RA   Bhat T.N., Blow D.M., Brick P., Nyborg J.;
RT   "Tyrosyl-tRNA synthetase forms a mononucleotide-binding fold.";
RL   J. Mol. Biol. 158:699-709(1982).
RN   [11] {ECO:0007744|PDB:1TYD, ECO:0007744|PDB:2TS1, ECO:0007744|PDB:3TS1}
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH TYROSINE.
RX   PubMed=2504923; DOI=10.1016/0022-2836(89)90090-9;
RA   Brick P., Bhat T.N., Blow D.M.;
RT   "Structure of tyrosyl-tRNA synthetase refined at 2.3-A resolution.
RT   Interaction of the enzyme with the tyrosyl adenylate intermediate.";
RL   J. Mol. Biol. 208:83-98(1989).
CC   -!- FUNCTION: Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-
CC       step reaction: tyrosine is first activated by ATP to form Tyr-AMP and
CC       then transferred to the acceptor end of tRNA(Tyr).
CC       {ECO:0000269|PubMed:10630994, ECO:0000269|PubMed:11023793,
CC       ECO:0000269|PubMed:11023794, ECO:0000269|PubMed:1542120,
CC       ECO:0000269|PubMed:6315404}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosine + tRNA(Tyr) = AMP + diphosphate + H(+) + L-
CC         tyrosyl-tRNA(Tyr); Xref=Rhea:RHEA:10220, Rhea:RHEA-COMP:9706,
CC         Rhea:RHEA-COMP:9707, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:58315, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78536, ChEBI:CHEBI:456215; EC=6.1.1.1;
CC         Evidence={ECO:0000269|PubMed:10630994, ECO:0000269|PubMed:11023793,
CC         ECO:0000269|PubMed:11023794, ECO:0000269|PubMed:11401566,
CC         ECO:0000269|PubMed:1542120};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.35 mM for ATP {ECO:0000269|PubMed:6315404};
CC         KM=1.8 uM for tyrosine {ECO:0000269|PubMed:6315404};
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:3006039}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       TyrS type 1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J01546; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X04193; CAA27784.1; -; Genomic_DNA.
DR   PIR; A01179; SYBSYF.
DR   RefSeq; WP_033014498.1; NZ_RCTK01000009.1.
DR   PDB; 1JH3; NMR; -; A=321-419.
DR   PDB; 1TYA; X-ray; 2.80 A; E=1-319.
DR   PDB; 1TYB; X-ray; 2.50 A; E=1-319.
DR   PDB; 1TYC; X-ray; 2.50 A; A=1-319.
DR   PDB; 1TYD; X-ray; 2.50 A; E=1-319.
DR   PDB; 2TS1; X-ray; 2.30 A; A=1-419.
DR   PDB; 3TS1; X-ray; 2.70 A; A=1-419.
DR   PDB; 4TS1; X-ray; 2.50 A; A/B=1-317.
DR   PDBsum; 1JH3; -.
DR   PDBsum; 1TYA; -.
DR   PDBsum; 1TYB; -.
DR   PDBsum; 1TYC; -.
DR   PDBsum; 1TYD; -.
DR   PDBsum; 2TS1; -.
DR   PDBsum; 3TS1; -.
DR   PDBsum; 4TS1; -.
DR   AlphaFoldDB; P00952; -.
DR   BMRB; P00952; -.
DR   SMR; P00952; -.
DR   GeneID; 58573035; -.
DR   BRENDA; 6.1.1.1; 623.
DR   SABIO-RK; P00952; -.
DR   EvolutionaryTrace; P00952; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IDA:CAFA.
DR   GO; GO:0005524; F:ATP binding; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0000049; F:tRNA binding; IDA:CAFA.
DR   GO; GO:0004831; F:tyrosine-tRNA ligase activity; IDA:CAFA.
DR   GO; GO:0061635; P:regulation of protein complex stability; IMP:CAFA.
DR   GO; GO:0006437; P:tyrosyl-tRNA aminoacylation; IDA:CAFA.
DR   CDD; cd00165; S4; 1.
DR   Gene3D; 3.10.290.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_02006; Tyr_tRNA_synth_type1; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002305; aa-tRNA-synth_Ic.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR002942; S4_RNA-bd.
DR   InterPro; IPR036986; S4_RNA-bd_sf.
DR   InterPro; IPR002307; Tyr-tRNA-ligase.
DR   InterPro; IPR024088; Tyr-tRNA-ligase_bac-type.
DR   InterPro; IPR024107; Tyr-tRNA-ligase_bac_1.
DR   PANTHER; PTHR11766; PTHR11766; 1.
DR   Pfam; PF01479; S4; 1.
DR   Pfam; PF00579; tRNA-synt_1b; 1.
DR   PRINTS; PR01040; TRNASYNTHTYR.
DR   SMART; SM00363; S4; 1.
DR   TIGRFAMs; TIGR00234; tyrS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
DR   PROSITE; PS50889; S4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Ligase; Nucleotide-binding;
KW   Protein biosynthesis; RNA-binding; tRNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:6840095"
FT   CHAIN           2..419
FT                   /note="Tyrosine--tRNA ligase"
FT                   /id="PRO_0000055642"
FT   DOMAIN          352..419
FT                   /note="S4 RNA-binding"
FT   MOTIF           39..48
FT                   /note="'HIGH' region"
FT                   /evidence="ECO:0000305|PubMed:11023794"
FT   MOTIF           230..234
FT                   /note="'KMSKS' region"
FT                   /evidence="ECO:0000305|PubMed:10630994"
FT   BINDING         34
FT                   /ligand="L-tyrosine"
FT                   /ligand_id="ChEBI:CHEBI:58315"
FT                   /evidence="ECO:0007744|PDB:1TYD"
FT   BINDING         169
FT                   /ligand="L-tyrosine"
FT                   /ligand_id="ChEBI:CHEBI:58315"
FT                   /evidence="ECO:0007744|PDB:1TYD"
FT   BINDING         173
FT                   /ligand="L-tyrosine"
FT                   /ligand_id="ChEBI:CHEBI:58315"
FT                   /evidence="ECO:0000250, ECO:0007744|PDB:1TYD"
FT   BINDING         176
FT                   /ligand="L-tyrosine"
FT                   /ligand_id="ChEBI:CHEBI:58315"
FT                   /evidence="ECO:0000250, ECO:0007744|PDB:1TYD"
FT   BINDING         233
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         40
FT                   /note="T->A: Destabilizes the transition states for both
FT                   steps of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023793"
FT   MUTAGEN         45
FT                   /note="H->A: Does not affect the second step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11023793,
FT                   ECO:0000269|PubMed:1542120"
FT   MUTAGEN         45
FT                   /note="H->N: Decreases the rate of formation of Tyr-AMP
FT                   and, as a consequence, abolishes the aminoacylation
FT                   activity. Strongly increases the toxicity; when associated
FT                   with A-152."
FT                   /evidence="ECO:0000269|PubMed:11023793,
FT                   ECO:0000269|PubMed:1542120"
FT   MUTAGEN         48
FT                   /note="H->A: Does not affect the second step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11023793"
FT   MUTAGEN         78
FT                   /note="D->A: Does not affect the initial binding of
FT                   tRNA(Tyr) and the stability of the transition state for the
FT                   second step of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023794"
FT   MUTAGEN         82
FT                   /note="K->A: Destabilizes the transition states for both
FT                   steps of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023793"
FT   MUTAGEN         86
FT                   /note="R->A: Destabilizes the transition states for both
FT                   steps of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023793"
FT   MUTAGEN         152
FT                   /note="E->A: Mischarges tRNA(Phe) with tyrosine in vitro.
FT                   Toxic for the cell, probably because it alters the
FT                   discrimination of TyrRS against non-cognate tRNAs. The
FT                   toxicity is abolished; when associated with N-410 or N-411.
FT                   Strongly increases toxicity; when associated with N-45.
FT                   Enhances the toxicity; when associated with A-224."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   MUTAGEN         152
FT                   /note="E->D: Does not charge tRNA(Phe) in vitro with
FT                   tyrosine."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   MUTAGEN         152
FT                   /note="E->Q: Mischarges tRNA(Phe) with tyrosine in vitro
FT                   but this mutation is not toxic in vivo."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   MUTAGEN         169
FT                   /note="Y->A: Does not affect the initial binding of
FT                   tRNA(Tyr) and the stability of the transition state for the
FT                   second step of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023794"
FT   MUTAGEN         173
FT                   /note="Q->A: Destabilizes the transition state for the
FT                   second step of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11023794"
FT   MUTAGEN         194
FT                   /note="D->A: Destabilizes the transition state for the
FT                   first step of the reaction, but does not affect the
FT                   transition state for the second step."
FT                   /evidence="ECO:0000269|PubMed:11023794"
FT   MUTAGEN         195
FT                   /note="Q->A: Destabilizes the transition state for the
FT                   first step of the reaction, but does not affect the
FT                   transition state for the second step."
FT                   /evidence="ECO:0000269|PubMed:11023794"
FT   MUTAGEN         224
FT                   /note="T->A: Is not toxic in itself. Enhances the toxicity;
FT                   when associated with A-152."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   MUTAGEN         230
FT                   /note="K->A: Decreases the binding affinity between
FT                   tRNA(Tyr) and TyrRS-Tyr-AMP complex."
FT                   /evidence="ECO:0000269|PubMed:10630994"
FT   MUTAGEN         231
FT                   /note="F->L: No effect on the binding affinity between
FT                   tRNA(Tyr) and TyrRS-Tyr-AMP complex."
FT                   /evidence="ECO:0000269|PubMed:10630994"
FT   MUTAGEN         232
FT                   /note="G->A: No effect on the binding affinity between
FT                   tRNA(Tyr) and TyrRS-Tyr-AMP complex."
FT                   /evidence="ECO:0000269|PubMed:10630994"
FT   MUTAGEN         233
FT                   /note="K->A: Decreases the binding affinity between
FT                   tRNA(Tyr) and TyrRS-Tyr-AMP complex."
FT                   /evidence="ECO:0000269|PubMed:10630994"
FT   MUTAGEN         234
FT                   /note="T->A: No effect on the binding affinity between
FT                   tRNA(Tyr) and TyrRS-Tyr-AMP complex."
FT                   /evidence="ECO:0000269|PubMed:10630994"
FT   MUTAGEN         322
FT                   /note="L->P: 50-fold decrease in charging of tRNA(Tyr) with
FT                   tyrosine."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         323
FT                   /note="F->A: 90-fold decrease in charging of tRNA(Tyr) with
FT                   tyrosine, without effect on the first step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         323
FT                   /note="F->L: 67-fold decrease in charging of tRNA(Tyr) with
FT                   tyrosine, without effect on the first step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         323
FT                   /note="F->W: Weak decrease in charging of tRNA(Tyr) with
FT                   tyrosine, without effect on the first step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         323
FT                   /note="F->Y: 3-fold decrease in charging of tRNA(Tyr) with
FT                   tyrosine, without effect on the first step of the
FT                   reaction."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         324
FT                   /note="S->A: 2-fold increase in charging of tRNA(Tyr) with
FT                   tyrosine."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         325
FT                   /note="G->A: 5-fold increase in charging of tRNA(Tyr) with
FT                   tyrosine."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         339
FT                   /note="F->L: Has no effect on charging of tRNA(Tyr) with
FT                   tyrosine."
FT                   /evidence="ECO:0000269|PubMed:11401566"
FT   MUTAGEN         410
FT                   /note="K->N: Decreases the binding of tRNA(Tyr), without
FT                   affecting the formation of Tyr-AMP. Abolishes the toxicity;
FT                   when associated with A-152."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   MUTAGEN         411
FT                   /note="K->N: Decreases the binding of tRNA(Tyr), without
FT                   affecting the formation of Tyr-AMP. Abolishes the toxicity;
FT                   when associated with A-152."
FT                   /evidence="ECO:0000269|PubMed:1542120"
FT   HELIX           2..10
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          14..17
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           19..28
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           46..48
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           49..60
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          64..69
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           73..75
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           91..105
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:1TYC"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           124..127
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           132..138
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           145..149
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           152..155
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   TURN            156..160
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           164..184
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          186..192
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           196..210
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          216..220
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          235..238
FT                   /evidence="ECO:0007829|PDB:4TS1"
FT   STRAND          240..242
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   TURN            243..245
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           248..256
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           260..270
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           275..287
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   TURN            289..291
FT                   /evidence="ECO:0007829|PDB:1TYB"
FT   HELIX           293..307
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   HELIX           309..318
FT                   /evidence="ECO:0007829|PDB:2TS1"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   HELIX           332..339
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   STRAND          344..347
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   HELIX           354..361
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   HELIX           367..375
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   STRAND          379..381
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   TURN            389..391
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   TURN            396..398
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   STRAND          399..408
FT                   /evidence="ECO:0007829|PDB:1JH3"
FT   STRAND          413..418
FT                   /evidence="ECO:0007829|PDB:1JH3"
SQ   SEQUENCE   419 AA;  47303 MW;  B9CB64AEEEE2010F CRC64;
     MDLLAELQWR GLVNQTTDED GLRKLLNEER VTLYCGFDPT ADSLHIGHLA TILTMRRFQQ
     AGHRPIALVG GATGLIGDPS GKKSERTLNA KETVEAWSAR IKEQLGRFLD FEADGNPAKI
     KNNYDWIGPL DVITFLRDVG KHFSVNYMMA KESVQSRIET GISFTEFSYM MLQAYDFLRL
     YETEGCRLQI GGSDQWGNIT AGLELIRKTK GEARAFGLTI PLVTKADGTK FGKTESGTIW
     LDKEKTSPYE FYQFWINTDD RDVIRYLKYF TFLSKEEIEA LEQELREAPE KRAAQKTLAE
     EVTKLVHGEE ALRQAIRISE ALFSGDIANL TAAEIEQGFK DVPSFVHEGG DVPLVELLVS
     AGISPSKRQA REDIQNGAIY VNGERLQDVG AILTAEHRLE GRFTVIRRGK KKYYLIRYA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024